Results 221 to 230 of about 538,505 (276)
Diagnostic challenges of atypical neuroleptic malignant syndrome after laparoscopic surgery for perforated peritonitis in a patient with class II obesity: a case report. [PDF]
Sakata K +5 more
europepmc +1 more source
Evaluation of Quality of Life in Patients with Malignant Dysphagia
Background In the last 10 years of clinical research there has been increasing interest in the evaluation of quality of life. Several generic and specific instruments have been developed for this purpose. EORTC QLQ C-30 is a cancer-specific questionnaire translated into various languages and validated in several
C, Brunelli +8 more
openaire +3 more sources
Treatment of malignant dysphagia with nitinol stents
Self-expanding nitinol stents were used in 22 patients for palliative treatment of malignant esophagogastric strictures. All patients but 5 were men (age range 47–75 years). The strictures were caused by squamous cell carcinoma (n = 12), adenocarcinoma (n = 8), and recurrent anastomotic carcinoma (n = 2).
B. Acunas +6 more
openaire +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Esophageal dilation in malignant dysphagia
Cancer, 1985Esophageal dilation by means of guided Neoplex (Medoc) tubes in 38 patients with malignant obstruction of the esophagus was analyzed. Peroral dilation proved to be a simple, well-tolerated primary procedure in the management of malignant strictures. Most patients have a temporary improvement of dysphagic symptoms, but the benefit appears to decrease ...
H, Aste +3 more
openaire +2 more sources
Endoscopic Palliation of Malignant Dysphagia
Mayo Clinic Proceedings, 2001Esophageal cancer is the primary cause of malignant dysphagia, a major cause of morbidity and mortality. In patients with esophageal cancer that is unresectable at the time of diagnosis, palliation is the major goal. Surgical treatment as well as radiation and chemoradiation therapy are traditional approaches for such patients.
D G, Adler, T H, Baron
openaire +2 more sources
Palliation of malignant dysphagia by laser therapy
Diseases of the Esophagus, 1997The outcome of 211 patients undergoing laser therapy as palliation for inoperable carcinoma of the esophagus is presented. The median age was 73 (range 44-97). The histology was adenocarcinoma for 127 patients and squamous-cell carcinoma for 84 patients.
A P, Savage +4 more
openaire +2 more sources
Photodynamic Therapy for Treatment of Malignant Dysphagia
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques, 1999Photodynamic therapy (PDT) was recently approved by the Food and Drug Administration for palliating obstructing esophageal cancer. This report reviews our initial experience using PDT to treat malignant dysphagia. Patients with inoperable, obstructing esophageal cancer were considered for PDT.
J D, Luketich +5 more
openaire +2 more sources

